138 related articles for article (PubMed ID: 10815277)
1. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
Latini R
Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277
[No Abstract] [Full Text] [Related]
2. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
[TBL] [Abstract][Full Text] [Related]
3. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
[TBL] [Abstract][Full Text] [Related]
4. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Mosller M
Clin Cardiol; 1997 Aug; 20(8):704-10. PubMed ID: 9259163
[TBL] [Abstract][Full Text] [Related]
5. Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
Torp-Pedersen C; Moller M; Kober L; Camm AJ
Eur Heart J; 2000 Aug; 21(15):1204-6. PubMed ID: 10924306
[No Abstract] [Full Text] [Related]
6. Management of heart failure.
Le Jemtel TH
Curr Cardiol Rep; 2000 May; 2(3):221-4. PubMed ID: 10980896
[No Abstract] [Full Text] [Related]
7. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L;
Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337
[TBL] [Abstract][Full Text] [Related]
8. Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
Brendorp B; Elming H; Jun L; Køber L; Torp-Pedersen C;
Eur J Heart Fail; 2002 Mar; 4(2):201-6. PubMed ID: 11959050
[TBL] [Abstract][Full Text] [Related]
9. [Dofetilide to patients with heart failure and left ventricular dysfunction].
Torp-Pedersen CT; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen JE; Videbaek J
Ugeskr Laeger; 2000 Oct; 162(44):5948-53. PubMed ID: 11094565
[TBL] [Abstract][Full Text] [Related]
10. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
Singh SN
Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
[TBL] [Abstract][Full Text] [Related]
11. Dofetilide for atrial fibrillation.
Rubin SA
N Engl J Med; 2000 Jan; 342(4):289-90. PubMed ID: 10660387
[No Abstract] [Full Text] [Related]
12. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
Pedersen OD; Brendorp B; Elming H; Pehrson S; Køber L; Torp-Pedersen C
Card Electrophysiol Rev; 2003 Sep; 7(3):220-4. PubMed ID: 14739717
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration.
Grines CL
Circulation; 2000 May; 101(21):E200-1. PubMed ID: 10831533
[No Abstract] [Full Text] [Related]
14. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.
DeCara JM; Pollak A; Dubrey S; Falk RH
Am J Cardiol; 2000 Sep; 86(6):685-8, A8. PubMed ID: 10980226
[TBL] [Abstract][Full Text] [Related]
15. Dofetilide for atrial fibrillation.
Ferraro P; Khawari A; Boden WE
N Engl J Med; 2000 Jan; 342(4):289; author reply 290. PubMed ID: 10660386
[No Abstract] [Full Text] [Related]
16. Atrial fibrillation in heart failure.
Stevenson WG; Stevenson LW
N Engl J Med; 1999 Sep; 341(12):910-1. PubMed ID: 10486424
[No Abstract] [Full Text] [Related]
17. Chemical cardioversion of atrial fibrillation with intravenous dofetilide.
Sedgwick ML; Lip G; Rae AP; Cobbe SM
Int J Cardiol; 1995 Apr; 49(2):159-66. PubMed ID: 7628887
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
Lindeboom JE; Kingma JH; Crijns HJ; Dunselman PH
Am J Cardiol; 2000 Apr; 85(8):1031-3. PubMed ID: 10760352
[No Abstract] [Full Text] [Related]
19. Dofetilide for atrial fibrillation.
Med Lett Drugs Ther; 2000 May; 42(1078):41-2. PubMed ID: 10847114
[No Abstract] [Full Text] [Related]
20. [Therapeutic aims for atrial fibrillation in patients with heart failure].
Lewalter T; Nitschmann S
Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
